1
Market Update for Week of August 15, 2025
The Week at a Glance:
Stocks Rally: Major indices finished the week up for the fourth out of five previous weeks thanks to strong earnings, resilient economic growth, and an increased likelihood of rate cuts
Sarepta Looks for a Lifeline: Sarepta sold its entire Arrowhead stake, raising ~$174M in cash to extend its runway while simultaneously using ~2.7M shares plus $50M cash to settle a $100M milestone owed to Arrowhead. This move comes amid financial challenges, including declining sales of Elevidys and recent FDA scrutiny following patient fatalities
Bayer Bets on KRASi: Bayer struck a deal worth up to $1.3B with Kumquat Biosciences to acquire global rights to a KRAS G12D inhibitor. Kumquat will run the drug through a Phase 1a study before Bayer takes over development, targeting cancers such as pancreatic, colorectal, and non-small cell lung cancer